Citius Oncology, Inc. is a biotechnology company focused on developing innovative therapies for cancer treatment. The company is dedicated to addressing unmet medical needs in oncology through its portfolio of proprietary drug candidates aimed at improving patient outcomes and enhancing the quality of life for those affected by cancer. Citius Oncology conducts advanced research and clinical trials to explore new treatment options, emphasizing the development of targeted therapies and combinations that leverage the immune system and novel mechanisms of action. Through its efforts, the company strives to contribute to the advancement of cancer care and expand available treatment modalities for patients enduring this challenging disease. Read More
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.
This week, several emerging stocks are capturing investor attention with headline-making developments across defense tech, mining, HR, crypto gaming, wellness, and AI-driven diagnostics.
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
Stay up-to-date with the latest market trends one hour before the close of the markets on Friday. Explore the top gainers and losers during today's session in our detailed report.
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top gainers and losers in today's session.
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.